Pfizer-BioNTech was said to have won a contract with the Philippines for the supply of the COVID-19 vaccine. It was reported that the country just signed a deal with the American multinational pharmaceutical and biotechnology company for 40 million doses of the vaccines.
The Philippines and Pfizer deal for coronavirus shots
As per Reuters, this is so far the biggest order of Pfizer COVID-19 vaccine from the Philippines. Secretary Carlito Galvez, the National Task Force chief against coronavirus, announced the deal with Pfizer on Sunday, June 20, and revealed that deliveries could be expected to begin in August.
In addition to this new order from Pfizer-BioNTech, the Philippines has now secured the delivery of 113 million doses of vaccine from five suppliers that include China's Sinovac (26 million doses), Moderna (20 million), Russia's Sputnik V (10 million) and AstraZeneca (17 million).
The vaccine supply in Manila is still limited and in some provinces, the government recorded a surge in COVID-19 cases, which complicates efforts to work up on the immunization drive. But with the upcoming Pfizer supply, officials are hoping that it will reach more people and eventually lessen the cases.
“We are very happy to report that the government and the management of Pfizer have finally concluded our negotiations, Philippine News Agency quoted Galvez as saying. “Health Secretary Francisco Duque and I signed yesterday (Saturday, June 19) the supply agreement for the biggest and most decisive deal we had for 2021.”
More vaccine jabs for the Filipinos
Galvez added that 20 million Filipinos will benefit from this Pfizer COVID-19 supply deal. The Philippines is not just waiting for deliveries from the American biotech company, but it is also expecting deliveries from the COVAX facility. In addition, a total of 16 million doses are coming from Jonhson & Johnson and Novavax as well.
Meanwhile, the Philippines will be allowing the administration of the Pfizer-BioNTech vaccines to youngsters ages 12 to 15. Their inoculation may begin later this year once the vaccine inventory expands and the priority group’s vaccinations are completed.


Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Instagram Outage Disrupts Thousands of U.S. Users
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 



